
Medvi Reviews
Summer Sale! up to $100 off
Last updated: Sep 14, 2026
Medically reviewed by Francheska Capistrano, RMT, MPH · · How we review
Medically reviewed by Francheska Capistrano, RMT, MPH · Medical Content Reviewer
Medically reviewed on Reviewed · Written by Treatments Hub Research Team
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
The bottom line
Medvi was already the most complete bundle in our ranking - provider visits, dietician access, care coaching and shipping in one HSA/FSA-eligible price. The current promotion changes the math: at $99/month semaglutide (regularly $199) and $166 tirzepatide (regularly $299), the all-inclusive program now costs within $30-40 of the bare-bones value tier (welludr $41, embody $49) while bundling care those providers don't.
As long as the promo holds, Medvi is arguably the best value-per-dollar in the ranking; at the $199/$299 regular rates, it goes back to being the premium-care pick. Needle-averse?
The $249 dissolving tablets remain one of the few needle-free GLP-1 formats we track.
Medvi products & prices
Published prices with their conditions - the whole card links to the provider.
Medvi's program is all-inclusive at one flat price, and its current promotion cuts that price roughly in half: weekly GLP-1 (semaglutide) injections now start at $89/month (regularly $199) and GLP-1/GIP (tirzepatide) at $166/month (regularly $299), with daily oral dissolving tablets at $249/month for the needle-averse - all with no membership fee, no hidden charges, free shipping, and free dietician and care coaching folded in. Plans are HSA/FSA approved.
At the $99 promotional rate, Medvi's all-inclusive bundle now competes directly with the value tier - the honest caveat is simply that promos can end; the regular rates are $199/$299.
Is Medvi legit?
Yes - Medvi is a legitimate medical weight-loss platform. Prescriptions are overseen by licensed providers with regular monitoring, and its pricing is transparent and all-inclusive with no surprise charges.
- Prescription treatment overseen by licensed providers
- Regular monitoring and provider check-ins
- Transparent, all-inclusive pricing - no surprise charges
- 100% online - no clinic visit required
“Legitimate” here means a real, licensed telehealth operation - not a guarantee of results. Compounded medications are not FDA-approved brand drugs. Always confirm current details and eligibility with the provider.
Key Features
- GLP-1 (semaglutide) injections now from $99/month (reg. $199)
- GLP-1/GIP (tirzepatide) injections from $166/month (reg. $299)
- Daily oral dissolving GLP-1 tablets at $249/month - no needles
- Video visits, free dietician and care coaching included
- HSA/FSA approved; no membership or hidden fees
Treatment Options
- GLP-1 (semaglutide) weekly injections
- GLP-1/GIP (tirzepatide) weekly injections
- Oral dissolving GLP-1 tablets - daily, needle-free
- Video visits, free dietician and care coaching
Pricing
GLP-1 Injections
WeeklyPrescription GLP-1 (semaglutide)
- One simple injection per week
- No membership or hidden fees - everything included
GLP-1 + GIP Injections
WeeklyPrescription GLP-1/GIP (tirzepatide)
- One simple injection per week
- All-inclusive - visits, coaching & shipping
GLP-1 Tablets
DailyOral dissolving GLP-1
- One dissolvable tablet per day
- No injections required
Medvi charges one flat, all-inclusive price, currently promotional: weekly GLP-1 (semaglutide) injections from $89/month (regularly $199), GLP-1/GIP (tirzepatide) from $166/month (regularly $299), and daily oral dissolving GLP-1 tablets at $249/month. The price covers the provider visits, the medication, free shipping, and free dietician and care coaching - there's no membership fee and no hidden charges, and plans are HSA/FSA approved.
At the promo rate the math gets aggressive: only welludr ($41) and embody ($49) list semaglutide cheaper, and neither bundles dietician access and coaching into the number.
What we verified
Checked September 2026
Every line below was checked against Medvi's own published pricing and plan information - not copied from other review sites. When we can't verify something, we leave it out rather than guess.
- Semaglutide price
- $99/month promotional (reg. $199), all-inclusive
- Tirzepatide price
- $166/month promotional (reg. $299)
- Support
- Video visits and a dietician on every plan
- Commitment
- Monthly, all-inclusive billing
Pros
- Current promo roughly halves the price: $89 semaglutide / $166 tirzepatide
- Genuinely all-inclusive pricing - visits, medication, shipping, coaching
- Needle-free option: daily oral dissolving tablets
- HSA/FSA approved; no membership or hidden fees
Cons
- The $99/$166 rates are promotional - regular prices are $199/$299
- The needle-free tablet option costs more ($249/month)
- No brand-name Ozempic/Wegovy/Zepbound shelf
- It's an ongoing monthly expense
Who It's Best For
- Anyone who wants dietician support and coaching bundled, not sold separately
- Needle-averse patients who want a daily dissolving tablet instead of injections
What Reddit says about Medvi
The most-upvoted recent Reddit threads about Medvi are full-year write-ups rather than first-week impressions. Excerpts from the real posts:
Medvi GLP-1 telehealth experience breakdown
“Within a few days, I heard back from a licensed provider... Most of the communication happened through secure messaging.”
“I did have some mild nausea when my dose increased, but it was manageable and improved after a short time... Around the middle of the year, progress slowed and I hit a plateau. I reached out through the messaging system, and my provider adjusted my dose, which helped me start moving again.”
“After about 12 months, I had lost just under 15 percent of my starting body weight... There were a couple times where replies took longer than expected, but nothing major. The main factor to consider is cost since it is an ongoing monthly expense.”
“It has not been effortless, but it has felt sustainable, which is something I had not experienced before.”
“Clinically speaking, losing around 10 to 15 percent of starting body weight over a year is very much within the expected and healthy range for semaglutide treatment.”
My 2026 MEDVI review after using it for a full year
“The first thing I noticed was that my appetite felt different in a calm manageable way rather than feeling like I was constantly fighting hunger.”
“Over the course of the year I lost just over 40 pounds and more importantly I've been able to maintain that loss without feeling burnt out.”
“After a full year I'd say Medvi was worth it for me. Not because it was a miracle solution but because it helped make sustainable weight loss feel possible again.”
“medvi is the best triz provider i ever had (changed 3 providers so far)”
“I've been using Medvi too and the biggest thing for me was exactly what you said, it quieted the food noise instead of turning weight loss into a daily mental fight.”
The takeaway: The Reddit picture is consistent: the ongoing monthly cost is the caveat users themselves raise - though Medvi's current $99/month promotion (regularly $199) blunts it considerably - but the year-long accounts describe exactly what that price buys: medical structure, dose adjustments when progress stalls, and 10-15% body-weight results over a year that felt “sustainable, which is something I had not experienced before.”
Excerpts from public Reddit posts, lightly trimmed; vote and comment counts shown as captured at the time of review. Reddit is a trademark of Reddit, Inc. and is not affiliated with this site. Posts are individual experiences, and any weight-loss result mentioned is one person’s and is not typical - results vary.
Final Verdict
Medvi was already the most complete bundle in our ranking - provider visits, dietician access, care coaching and shipping in one HSA/FSA-eligible price. The current promotion changes the math: at $99/month semaglutide (regularly $199) and $166 tirzepatide (regularly $299), the all-inclusive program now costs within $30-40 of the bare-bones value tier (welludr $41, embody $49) while bundling care those providers don't.
As long as the promo holds, Medvi is arguably the best value-per-dollar in the ranking; at the $199/$299 regular rates, it goes back to being the premium-care pick. Needle-averse?
The $249 dissolving tablets remain one of the few needle-free GLP-1 formats we track.
Medvi Review: FAQs
Is Medvi legit?
Yes - Medvi is a legitimate medical weight-loss platform. Prescriptions are overseen by licensed providers with regular monitoring, and its pricing is transparent and all-inclusive with no surprise charges.
How much does Medvi cost?
Medvi charges one flat, all-inclusive price, currently promotional: weekly GLP-1 (semaglutide) injections from $89/month (regularly $199), GLP-1/GIP (tirzepatide) from $166/month (regularly $299), and daily oral dissolving GLP-1 tablets at $249/month. The price covers the provider visits, the medication, free shipping, and free dietician and care coaching - there's no membership fee and no hidden charges, and plans are HSA/FSA approved. At the promo rate the math gets aggressive: only welludr ($41) and embody ($49) list semaglutide cheaper, and neither bundles dietician access and coaching into the number.
What treatments does Medvi offer?
Medvi offers GLP-1 (semaglutide) weekly injections, GLP-1/GIP (tirzepatide) weekly injections, Oral dissolving GLP-1 tablets - daily, needle-free, Video visits, free dietician and care coaching.
Who is Medvi best for?
Medvi is best for Anyone who wants dietician support and coaching bundled, not sold separately; Needle-averse patients who want a daily dissolving tablet instead of injections.
Is Medvi worth it?
Medvi was already the most complete bundle in our ranking - provider visits, dietician access, care coaching and shipping in one HSA/FSA-eligible price. The current promotion changes the math: at $99/month semaglutide (regularly $199) and $166 tirzepatide (regularly $299), the all-inclusive program now costs within $30-40 of the bare-bones value tier (welludr $41, embody $49) while bundling care those providers don't. As long as the promo holds, Medvi is arguably the best value-per-dollar in the ranking; at the $199/$299 regular rates, it goes back to being the premium-care pick. Needle-averse? The $249 dissolving tablets remain one of the few needle-free GLP-1 formats we track.
What does Medvi's monthly price actually include?
Everything: the provider visits, the GLP-1 medication, free shipping, and free dietician and care coaching. There's no membership fee and no hidden charges, and plans are HSA/FSA approved.
Does Medvi have a needle-free option?
Yes - Medvi offers a daily oral dissolving GLP-1 tablet at $249/month, one of the few needle-free GLP-1 formats among the providers we rank. Weekly semaglutide injections currently start at $99/month (regularly $199).
Do I need insurance for Medvi?
No - Medvi is a cash-pay program with one flat all-inclusive price, no insurance and no prior authorization required. Plans are HSA/FSA approved if you want to pay with pre-tax health funds.
Not sure if Medvi is right for you?
Take our free quiz and get a personalized provider recommendation.
Find Your MatchRelated
Head-to-head
Three-way comparisons
Guides
More on Medvi
The questions people ask before signing up - answered in depth.
Sources & methodology
We built this review of Medvi from the provider'sown published pricing, plans and policies, cross-checked against regulatory and peer-reviewed medical references, and read alongside real customer feedback. Prices and plan details were verified against the provider's published information; we do not take providers' word for their own claims without checking.
Provider information
Pricing, plans, shipping and policies, checked against each provider's own site.
- Medvi - pricing, plans & policies as published on its own site
Provider data checked September 2026
Customer & community feedback
Third-party signals shown on this page and in our full reviews: public Reddit discussions and independent YouTube reviews. We report what these sources say - we never fold them into our own scores.
Medical & regulatory references
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)
Last reviewed September 2026. We revisit comparisons when providers change their pricing or policies. This page is information only and is not medical advice - always consult a licensed clinician before starting treatment.
Medical disclaimer
This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.
Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.
Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)


